Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abbott Laboratories

Abbott Laboratories (ABT) Stock Overview

Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.

ABT●NYSE
HealthcareMedical - Devices
$101.07
$2.42(2.34%)
U.S. Market opens in 3h 30m

Abbott Laboratories (ABT)

Meyka AI Score

Z

Key Financials

Market Cap174.9B
P/E Ratio32.61
EPS (TTM)$5.21
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$95.20
3 Months$81.51
1 Year Target$121.76

ABT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Abbott Laboratories (NYSE: ABT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Abbott Laboratories's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABT on the NYSE shows an RSI of 35.01, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $121.76 for the NYSE listing.

Key metrics behind Abbott Laboratories's NYSE-traded stock include a P/E ratio of 32.61 and a market capitalization of 174.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABT on the NYSE.

Price Performance (NYSE: ABT)

1-Day Change
-2.32%
5-Day Change
-0.73%
1-Month Change
-13.35%
3-Month Change
11.71%
6-Month Change
-2.85%
Year-to-Date (YTD) Change
-19.32%
1-Year Change
-24.50%
3-Year Change
3.71%
5-Year Change
-18.72%
All-Time (Max) Change
61296.90%

Contact Information

https://www.abbott.com
224 667 6100
100 Abbott Park Road, Abbott Park, IL, 60064-6400

Company Facts

1,150,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions